StockStory.org on MSN
Testing & diagnostics services stocks Q1 results: Benchmarking RadNet (NASDAQ:RDNT)
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics ...
Hosted on MSN
Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth
CEO Christopher Hall reported Q1 2025 revenue of $20.6 million, marking a strong start to the year. He highlighted significant progress in their "Win-in-MRD" strategy, driven by demand for the company ...
July 29 (Reuters) - Teradyne (TER.O), opens new tab beat Wall Street estimates for second-quarter revenue on Tuesday, helped by steady demand for the company's semiconductor-testing equipment, sending ...
Leading semiconductor packaging and testing company ASE expects that fourth quarter revenue in NTD will grow 1-2% quarter-over-quarter, while semiconductor assembly and test materials (ATM) revenue is ...
King Yuan Electronics Co. (KYEC), a global leader in semiconductor testing, announced a robust financial performance for February 2026. The company reported monthly revenue of NT$3.22 billion (approx.
Oncocyte Corp. reports Q4 2024 revenue of $1.5 million, launching a new transplant assay and securing strategic partnerships. Oncocyte Corp. reported a revenue of $1.5 million for Q4 2024 and a ...
April 28 (Reuters) - Teradyne (TER.O), opens new tab on Monday forecast second-quarter revenue above Wall Street expectations and beat estimates for quarterly profit and revenue, helped by steady ...
TAIPEI (Reuters) - ASE Technology Holding Co., the world's largest chip packaging and testing provider, said on Thursday it expects its revenue from leading-edge advanced packaging and testing to more ...
Tech International (NYSE American: TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced financial results for ...
The global prenatal and newborn genetic testing market is projected to witness strong growth and is expected to expand at a CAGR of nearly 14% over the next five years. Rising prevalence of genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results